Exane Derivatives’s Summit Materials, Inc. Class A Common Stock SUM Stock Holding History

Exane Derivatives’s Portfolio SUM Stock Details SUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,999	Closed	-$428K	–	1048
2022 Q1	$428K	Buy	+13,999	New	+$466K	0.12%	209
2021 Q4	–	Sell	-10,295	Closed	-$324K	–	1096
2021 Q3	$324K	Sell	10,295 -5,812	-36%	-$190K	0.08%	266
2021 Q2	$544K	Buy	16,107 +12,826	+391%	+$404K	0.12%	170
2021 Q1	$90.4K	Buy	3,281 +690	+27%	+$17.3K	0.03%	434
2020 Q4	$51.2K	Buy	2,591 +1,100	+74%	+$20.4K	0.02%	452
2020 Q3	$24.2K	Buy	+1,491	New	+$23.9K	0.01%	421

Other funds holding SUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Exane Derivatives's SUM Position: Q2 2022 in Review

Exane Derivatives sold out of Summit Materials, Inc. Class A Common Stock (SUM) in Q2 2022, closing a stake of 13,999 shares — an estimated $428K sold.

Exane Derivatives first reported a position in SUM in Q3 2020 and held it in 6 quarters. The position peaked at $544K in Q2 2021. 237 funds tracked by Wall St. Rank hold SUM as of Q2 2022.

Exane Derivatives reported no remaining Summit Materials, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 13,999 Summit Materials, Inc. Class A Common Stock shares in Q2 2022, an estimated $428K.
Exane Derivatives first reported a position in Summit Materials, Inc. Class A Common Stock in Q3 2020 and held it in 6 quarters.
Exane Derivatives's Summit Materials, Inc. Class A Common Stock position peaked at $544K in Q2 2021.
237 funds tracked by Wall St. Rank held Summit Materials, Inc. Class A Common Stock as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.